Dinh, Tam Nguyen <br/><br/>
Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.  [electronic resource] 

 -  Circulation  Sep 2012 
 - 1256-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.112.099044  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antibodies, Neutralizing--immunology<br/>Antigen-Antibody Complex--immunology<br/>Apolipoproteins E--genetics<br/>Atherosclerosis--drug therapy<br/>Biomarkers--metabolism<br/>CD4 Antigens--metabolism<br/>Cell Division--drug effects<br/>Dietary Fats--pharmacology<br/>Disease Models, Animal<br/>Disease Progression<br/>Dose-Response Relationship, Immunologic<br/>Forkhead Transcription Factors--metabolism<br/>Interleukin-2--immunology<br/>Interleukin-2 Receptor alpha Subunit--metabolism<br/>Male<br/>Mice<br/>Mice, Mutant Strains<br/>T-Lymphocytes, Regulatory--drug effects